Abstract:Background: Epstein-Barr virus (EBV)-associated hemophagocytic lymphohistiocytosis (EBV-HLH) is a common subtype of HLH with heterogeneous clinical presentations from self-limited to death, of which adults are worse than children. Objective: To establish predictors of mortality risk in adult EBV-HLH patients for timely and appropriate treatment. Methods: Patients with confirmed EBV-HLH admitted to Beijing Friendship Hospital from January 2015 to December 2019 were enrolled and statistical analysis of their laboratory test results was performed. Results: Among 246 adult patients with EBV-HLH, the deceased were older (p < 0.05), with fewer blood cells (p < 0.05), poorer renal function (p < 0.01), higher levels of procalcitonin (PCT) (p < 0.01), as well as soluble interleukin-2 receptor (sCD25) (p < 0.01). The overall median survival time of patients was 135 days, 87 days for patients without transplantation and 294 days with transplantation (p < 0.001). A combined index of sCD25, PCT, and estimated glomerular filtration rate (eGFR) was obtained to predict prognosis, named the Improved HLH index (IH index), and patients were divided into three groups meeting IH- (i.e. sCD25 ≤ 18,000 pg/mL, PCT ≤ 1.8 ng/mL, eGFR ≥ 90 mL/min/1.73m2), IH1+ (i.e. only sCD25 > 18,000 pg/mL or only eGFR < 90 mL/min/1.73m2), and IH2+ (i.e. the rest), respectively. In patients with the HScore ≥ 169 or meeting HLH-04, those meeting IH2+ had significantly worse prognoses than those who met IH1+ or IH- (p < 0.001). In the group meeting IH + or IH2+, patients who received allo-HSCT had better prognoses than those who did not (p < 0.05), but there was still a significant difference in prognosis among the three groups in transplanted patients (p < 0.001). Conclusion: The IH index can early identify adult patients with a poor prognosis of EBV-HLH, initiating timely and appropriate treatment.KEY MESSAGESA combined index of sCD25, PCT, and eGFR was obtained to predict prognosis, named the Improved Hemophagocytic Lymphohistiocytosis index (IH index).IH index can early identify adult patients with a poor prognosis of EBV-HLH, initiating timely and appropriate treatment.

An effective diagnostic index for lymphoma-associated hemophagocytic syndrome.

Clinical Features and Prognostic Analysis of Lymphoma-Associated Hemophagocytic Syndrome: A Report of 139 Cases

Adult Onset Haemophagocytic Lymphohistiocytosis Prognosis is Affected by Underlying Disease: Analysis of a Single-Institution Series of 174 Patients.

Identification of Clinical Features of Lymphoma-Associated Hemophagocytic Syndrome (LAHS): an Analysis of 69 Patients with Hemophagocytic Syndrome from a Single-Center in Central Region of China.

Serum Soluble VSIG4 As a Surrogate Marker for the Diagnosis of Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.

Clinical Characteristics And Prognosis Of Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective Study Of 67 Adult Chinese Patients

Prognostic Factors of Early Death in Children with Hemophagocytic Lymphohistiocytosis.

Lymphoma-associated Hemophagocytic Syndrome: a Retrospective Study from a Single Center.

Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation

Clinical Features and Prognostic Risk Prediction of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome

Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients

Clinical features and treatment outcome of non-Hodgkin’s lymphoma-associated hemophagocytic syndrome：report of32cases

Clinical Analysis and Prognostic Significance of Lymphoma-Associated Hemophagocytosis in Peripheral T Cell Lymphoma

Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis

Diagnostic Accuracy of a Specific Cytokine Pattern in Hemophagocytic Lymphohistiocytosis in Children.

Lymphoma-associated hemophagocytic syndrome: an analysis of clinical features and survival of 27 cases from a single center in China

Immune Microenvironment Associated with the Severity of Langerhans Cell Histiocytosis in Children.

A Clinical Study of 21 Patients with Hemophagocytic Syndrome in 295 Cases Diagnosed with Nasal Type, Extranodal Nature Killer/T Cell Lymphoma

The clinical diagnosis, treatment and prognosis of lymphoma-associated hemophagocytic syndrome: A report of three cases and literature review

Improved hemophagocytic lymphohistiocytosis index predicts prognosis of adult Epstein-Barr virus-associated HLH patients

Early Diagnostic And Prognostic Significance Of A Specific Th1/Th2 Cytokine Pattern In Children With Haemophagocytic Syndrome